ATE358495T1 - Verwendung von einem chrysanthellum indicum extrakt zur behandlung der akne rosacea - Google Patents

Verwendung von einem chrysanthellum indicum extrakt zur behandlung der akne rosacea

Info

Publication number
ATE358495T1
ATE358495T1 AT03763945T AT03763945T ATE358495T1 AT E358495 T1 ATE358495 T1 AT E358495T1 AT 03763945 T AT03763945 T AT 03763945T AT 03763945 T AT03763945 T AT 03763945T AT E358495 T1 ATE358495 T1 AT E358495T1
Authority
AT
Austria
Prior art keywords
acne rosacea
treat acne
chrysanthellum indicum
indicum extract
extract
Prior art date
Application number
AT03763945T
Other languages
English (en)
Inventor
Nicolas Fouchere
Original Assignee
Sicobel Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicobel Lab filed Critical Sicobel Lab
Application granted granted Critical
Publication of ATE358495T1 publication Critical patent/ATE358495T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT03763945T 2002-07-11 2003-07-09 Verwendung von einem chrysanthellum indicum extrakt zur behandlung der akne rosacea ATE358495T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0208753A FR2842109B1 (fr) 2002-07-11 2002-07-11 Utilisation d'un extrait de chrysanthellum

Publications (1)

Publication Number Publication Date
ATE358495T1 true ATE358495T1 (de) 2007-04-15

Family

ID=29763755

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03763945T ATE358495T1 (de) 2002-07-11 2003-07-09 Verwendung von einem chrysanthellum indicum extrakt zur behandlung der akne rosacea

Country Status (8)

Country Link
EP (1) EP1521586B1 (de)
AT (1) ATE358495T1 (de)
AU (1) AU2003264707A1 (de)
CA (1) CA2494001C (de)
DE (1) DE60312988T2 (de)
ES (1) ES2285187T3 (de)
FR (1) FR2842109B1 (de)
WO (1) WO2004006943A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902335B1 (fr) * 2006-06-16 2010-09-10 Nuxe Lab Utilisation d'un extrait de mimosa dans une composition cosmetique.
ES2412506B1 (es) * 2011-12-23 2014-03-26 Laboratorios Viñas S.A. Composición dermatológica para el tratamiento tópico de la rosácea y procedimiento y uso correspondientes
JP2013060460A (ja) * 2012-12-17 2013-04-04 Kao Corp Ｎｆａｔシグナル阻害剤及びｎｆａｔシグナル阻害方法
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
IT202100002735A1 (it) 2021-02-08 2022-08-08 Phytoitalia Srl Metodo di estrazione e arricchimento di flavonoidi monoglicosilati da chrysanthellum indicum per il trattamento di patologie poliartritiche su base infiammatoria, per l'uso in dispositivi cosmetici, nutraceutici, medici e applicazioni farmaceutiche

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2276060A1 (fr) * 1974-06-27 1976-01-23 Cortial Procede de purification d'extraits de chrysanthellum et produits en resultant
FR2378044A1 (fr) * 1977-01-20 1978-08-18 Sarget Lab Nouvel extrait vegetal a partir de varietes de chrysanthellum
FR2456116A1 (fr) * 1979-05-11 1980-12-05 Sarget Lab Nouvelle saponine triterpenique derivee de la caulophyllogenine et ses applications therapeutiques
FR2618071B1 (fr) * 1987-07-17 1991-05-24 Guillot Bernard Compositions cosmetiques et dermatologiques a base d'extraits de chrysanthellum
FR2755609B1 (fr) * 1996-11-14 1998-12-24 Lanatech Composition pour la prevention du vieillissement cutane

Also Published As

Publication number Publication date
EP1521586B1 (de) 2007-04-04
AU2003264707A1 (en) 2004-02-02
WO2004006943A2 (fr) 2004-01-22
CA2494001C (fr) 2010-01-26
DE60312988T2 (de) 2007-12-13
DE60312988D1 (de) 2007-05-16
EP1521586A2 (de) 2005-04-13
FR2842109A1 (fr) 2004-01-16
FR2842109B1 (fr) 2007-06-08
CA2494001A1 (fr) 2004-01-22
WO2004006943A3 (fr) 2004-04-08
ES2285187T3 (es) 2007-11-16

Similar Documents

Publication Publication Date Title
ATE372341T1 (de) Inhibitoren von mitotischem kinesin
ATE421512T1 (de) Inhibitoren von mitotischem kinesin
EP1515724A4 (de) Mitotische kinesin-hemmer
ATE424388T1 (de) Mitotische kinesinhemmer
ATE447577T1 (de) Mitotische kinesin-hemmer
ATE356804T1 (de) Inhibitoren von mitotischem kinesin
ATE387194T1 (de) Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung
ATE470439T1 (de) Verwendung von hif 1alfa modulatoren zur behandlung von krebs
ATE408412T1 (de) Verwendung von cannabidiol zur hemmung von gehirntumorzellmigration
EA200870415A1 (ru) Хиназолины для ингибирования pdk 1
BRPI0519424A2 (pt) composiÇÕes e mÉtodos para tratamento de distérbios de proliferaÇço celular
ATE552000T1 (de) Verwendung von isothiocyanat-verbindungen zur behandlung von prostata-erkrankungen und hautkrebs
NO20091661L (no) Anvendelse av pegylert IL-10 for a behandle kreft
PE20020521A1 (es) Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas
WO2004039774A3 (en) Mitotic kinesin inhibitors
WO2003099211A3 (en) Mitotic kinesin inhibitors
ATE483462T1 (de) Verwendung der epothilons zur behandlung der krebs
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
WO2005065183A3 (en) Mitotic kinesin inhibitors
WO2005060654A3 (en) Mitotic kinesin inhibitors
DE60328603D1 (de) Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren
ATE222119T1 (de) Verwendung von erythropoietin zur behandlung von multiple myelom
EA200800374A1 (ru) 1,4-дигидропиридин-конденсированные гетероциклы, способы их получения, применение и содержащие их композиции
ATE358495T1 (de) Verwendung von einem chrysanthellum indicum extrakt zur behandlung der akne rosacea
EP1635641A4 (de) Inhibitoren von mitotischem kinesin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1521586

Country of ref document: EP

REN Ceased due to non-payment of the annual fee